【结 构 式】 |
【药物名称】GW-273629 【化学名称】2(R)-Amino-3-[2-(1-iminoethylamino)ethylsulfonyl]propionic acid 【CA登记号】 【 分 子 式 】C7H15N3O4S 【 分 子 量 】237.2793 |
【开发单位】GlaxoSmithKline (Originator) 【药理作用】ANALGESIC AND ANESTHETIC DRUGS, Analgesic Drugs, CARDIOVASCULAR DRUGS, Treatment of Shock, Inducible Nitric Oxide Synthase (NOS-2) Inhibitors |
合成路线1
Reductive cleavage of L-cystine (I) with sodium in liquid ammonia produced cysteine, which was subsequently alkylated with 2-(N-benzyloxycarbonylamino)ethyl tosylate (II) to afford thioether (III). After protection of (III) as the N-Boc derivative (IV), sulfur oxidation by means of Oxone(R) produced sulfone (V). The benzyloxycarbonyl protecting group of (V) was then cleaved by transfer hydrogenolysis employing formic acid and palladium catalyst, and the resulting amine (VI) was converted to amidine (VIII) by reaction thioacetimidate (VII). The Boc protecting group of (VIII) was finally removed by acidic treatment.
【1】 Young, R.J.; et al.; Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine. Bioorg Med Chem Lett 2000, 10, 6, 597. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 42188 | (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propionic acid | C6H12N2O4S2 | 详情 | 详情 | |
(II) | 42170 | 2-[[(benzyloxy)carbonyl]amino]ethyl 4-methylbenzenesulfonate | C17H19NO5S | 详情 | 详情 | |
(III) | 42189 | (2R)-2-amino-3-[(2-[[(benzyloxy)carbonyl]amino]ethyl)sulfanyl]propionic acid | C13H18N2O4S | 详情 | 详情 | |
(IV) | 42190 | (2R)-3-[(2-[[(benzyloxy)carbonyl]amino]ethyl)sulfanyl]-2-[(tert-butoxycarbonyl)amino]propionic acid | C18H26N2O6S | 详情 | 详情 | |
(V) | 42191 | (2R)-3-[(2-[[(benzyloxy)carbonyl]amino]ethyl)sulfonyl]-2-[(tert-butoxycarbonyl)amino]propionic acid | C18H26N2O8S | 详情 | 详情 | |
(VI) | 42192 | (2R)-3-[(2-aminoethyl)sulfonyl]-2-[(tert-butoxycarbonyl)amino]propionic acid | C10H20N2O6S | 详情 | 详情 | |
(VII) | 42175 | 1-naphthylmethyl ethanimidothioate | C13H13NS | 详情 | 详情 | |
(VIII) | 42193 | (2R)-2-[(tert-butoxycarbonyl)amino]-3-[[2-(ethanimidoylamino)ethyl]sulfonyl]propionic acid | C12H23N3O6S | 详情 | 详情 |
合成路线2
In a related procedure, N-Boc-L-cysteine tert-butyl ester (X) was prepared by reduction of N-Boc-cystine tert-butyl ester (IX) with dithiothreitol (DTT). Alkylation of thiol (X) with tosylate (II) afforded thioether (XI). After oxidation of (XI) to sulfone (XII), transfer hydrogenolysis using ammonium formate and palladium hydroxide on carbon removed the benzyloxycarbonyl group to furnish amine (XIII). This was converted to amidine (XIV) by treatment with thioacetimidate (VII). Finally, deprotection of the Boc group and the tert-butyl ester of (XIV) by means of HCl in dioxan afforded the title compound.
【1】 Young, R.J.; et al.; Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine. Bioorg Med Chem Lett 2000, 10, 6, 597. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(II) | 42170 | 2-[[(benzyloxy)carbonyl]amino]ethyl 4-methylbenzenesulfonate | C17H19NO5S | 详情 | 详情 | |
(VII) | 42175 | 1-naphthylmethyl ethanimidothioate | C13H13NS | 详情 | 详情 | |
(IX) | 42194 | di(tert-butyl) (6R,11R)-2,2,15,15-tetramethyl-4,13-dioxo-3,14-dioxa-8,9-dithia-5,12-diazahexadecane-6,11-dicarboxylate | C24H44N2O8S2 | 详情 | 详情 | |
(X) | 42195 | tert-butyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-sulfanylpropanoate | C12H23NO4S | 详情 | 详情 | |
(XI) | 42196 | tert-butyl (2R)-3-[(2-[[(benzyloxy)carbonyl]amino]ethyl)sulfanyl]-2-[(tert-butoxycarbonyl)amino]propanoate | C22H34N2O6S | 详情 | 详情 | |
(XII) | 42197 | tert-butyl (2R)-3-[(2-[[(benzyloxy)carbonyl]amino]ethyl)sulfonyl]-2-[(tert-butoxycarbonyl)amino]propanoate | C22H34N2O8S | 详情 | 详情 | |
(XIII) | 42198 | tert-butyl (2R)-3-[(2-aminoethyl)sulfonyl]-2-[(tert-butoxycarbonyl)amino]propanoate | C14H28N2O6S | 详情 | 详情 | |
(XIV) | 42199 | tert-butyl (2R)-2-[(tert-butoxycarbonyl)amino]-3-[[2-(ethanimidoylamino)ethyl]sulfonyl]propanoate | C16H31N3O6S | 详情 | 详情 |